1. Home
  2. CRMD vs NLOP Comparison

CRMD vs NLOP Comparison

Compare CRMD & NLOP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CRMD
  • NLOP
  • Stock Information
  • Founded
  • CRMD 2006
  • NLOP N/A
  • Country
  • CRMD United States
  • NLOP United States
  • Employees
  • CRMD N/A
  • NLOP N/A
  • Industry
  • CRMD Biotechnology: Pharmaceutical Preparations
  • NLOP
  • Sector
  • CRMD Health Care
  • NLOP
  • Exchange
  • CRMD Nasdaq
  • NLOP Nasdaq
  • Market Cap
  • CRMD 464.7M
  • NLOP 411.5M
  • IPO Year
  • CRMD 2010
  • NLOP N/A
  • Fundamental
  • Price
  • CRMD $8.50
  • NLOP $28.53
  • Analyst Decision
  • CRMD Strong Buy
  • NLOP Strong Buy
  • Analyst Count
  • CRMD 6
  • NLOP 1
  • Target Price
  • CRMD $14.50
  • NLOP $46.00
  • AVG Volume (30 Days)
  • CRMD 2.6M
  • NLOP 106.5K
  • Earning Date
  • CRMD 05-08-2025
  • NLOP 01-01-0001
  • Dividend Yield
  • CRMD N/A
  • NLOP 1.19%
  • EPS Growth
  • CRMD N/A
  • NLOP N/A
  • EPS
  • CRMD N/A
  • NLOP N/A
  • Revenue
  • CRMD $43,472,170.00
  • NLOP $142,247,000.00
  • Revenue This Year
  • CRMD $207.65
  • NLOP N/A
  • Revenue Next Year
  • CRMD $50.13
  • NLOP N/A
  • P/E Ratio
  • CRMD N/A
  • NLOP N/A
  • Revenue Growth
  • CRMD N/A
  • NLOP N/A
  • 52 Week Low
  • CRMD $3.61
  • NLOP $22.36
  • 52 Week High
  • CRMD $13.85
  • NLOP $34.38
  • Technical
  • Relative Strength Index (RSI)
  • CRMD 57.04
  • NLOP 44.39
  • Support Level
  • CRMD $6.32
  • NLOP $27.66
  • Resistance Level
  • CRMD $7.71
  • NLOP $28.75
  • Average True Range (ATR)
  • CRMD 0.49
  • NLOP 1.16
  • MACD
  • CRMD 0.32
  • NLOP 0.04
  • Stochastic Oscillator
  • CRMD 97.64
  • NLOP 44.02

About CRMD CorMedix Inc.

Cormedix Inc is a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions. The Company's focus is on the commercialization of its product, DefenCath, in the United States (U.S.) and other key markets. The group currently operates in a single segment, Drug Product, located in a single geographic location, the United States.

About NLOP Net Lease Office Properties of Beneficial Interest

Net Lease Office Properties is a Maryland real estate investment trust that, together with its consolidated subsidiaries, owns a diversified portfolio of office properties that are primarily leased to corporate tenants on a single-tenant, net-lease basis. Its net leases generally specify a base rent with rent increases and require the tenant to pay substantially all costs associated with operating and maintaining the property. Its portfolio includes approximately 1.2 million square feet of Green-Certified Buildings, 2 LEED-certified buildings, and 1 BREEAM-certified building.

Share on Social Networks: